Zyvex Pharmaceuticals Cardarine GW-501516 20 mg Research Pack
Out of stock
Injection · 5 mg · vial
Zyvex Pharmaceuticals TB-500 is a 5 mg lyophilized vial of a synthetic thymosin beta-4 fragment, a research peptide studied for soft-tissue repair and cell migration. Available for purchase as TB-500 5 mg, a single research vial.
GMP-manufactured, HPLC-verified with the Certificate of Analysis on file. TB-500 for sale with international shipping with a 4 to 10 day transit window.
Zyvex Pharmaceuticals TB-500 is a 5 mg lyophilized vial of a synthetic fragment of thymosin beta-4, the peptide studied for cell migration and soft-tissue repair. Buy TB-500 as a research material, not as a medicine: no human half-life and no human dose have been established for it, and the figures that circulate in gyms come from a vendor protocol rather than from a trial. The vial needs bacteriostatic water before use.
The peptide is described in the literature in terms of actin regulation and cell migration, the biological basis for the repair claims about it. The pharmacokinetic picture is thin: the checked source file records that the human half-life is not established at all, and that detection work has only been done in veterinary studies, where the N-acetylated metabolite LKKTETQ was measured in horse urine and plasma. There is no human detection window to quote. The substance is named on the WADA prohibited list in class S2, so it is off limits for any tested athlete.
Add bacteriostatic water down the wall and swirl, do not shake. Divide the milligrams on the vial by the millilitres added: 5 mg with 2 ml reads 2.5 mg/ml, which makes the vendor protocol easy to follow on a U-100 syringe. That protocol is a loading phase of 2.0 to 2.5 mg twice a week for four weeks and then 2.0 to 2.5 mg once a week, so a single 5 mg vial covers roughly one week of loading or two to two and a half weeks of maintenance. It is usually discussed with the locally acting Zyvex BPC-157 vial, and other lines here carry the same peptide as TB-500 2 to 10 mg vials, and the Axiolabs entry as TB 500 5 mg. Keep the powder cold and the mixed solution refrigerated.
Each batch is produced under GMP conditions and checked by HPLC, with the Certificate of Analysis held for the batch. Store the lyophilized vial at 2-8 C or colder, protected from light, and keep the reconstituted solution refrigerated rather than frozen.
For laboratory research only. Consult a healthcare professional before use.
| Brand | Zyvex Pharmaceuticals |
| Active Substance | TB-500, thymosin beta-4 fragment |
| Dosage | 5 mg per vial |
| Package | 1 lyophilized vial |
| Form | Lyophilized powder, requiring reconstitution |
| Drug Class | Research peptide, WADA class S2 |
| Manufacturing | GMP-certified |
| Testing | HPLC per batch, COA on file |
| Shipping | International, 4-10 days transit |
Before you ask
It is a 5 mg lyophilized vial of a synthetic fragment of thymosin beta-4, supplied by Zyvex Pharmaceuticals as research material. TB-500 is studied in the context of cell migration and soft-tissue repair, and the sources checked for this card record no established human half-life and no human dosing, so the vial is laboratory material rather than a licensed medicine.
Add bacteriostatic water down the side of the vial and swirl, never shake. Divide the milligrams by the millilitres: 5 mg with 2 ml gives 2.5 mg/ml, so 1 mg reads as 40 units on a U-100 syringe. Keep the sealed powder cold and the mixed solution refrigerated, and use it within the short window that a reconstituted peptide allows.
The source file records a vendor protocol rather than a clinical one: a loading phase of 2.0 to 2.5 mg twice a week for the first four weeks, then a maintenance phase of 2.0 to 2.5 mg once a week. On that schedule a single 5 mg vial covers about one week of loading or two to two and a half weeks of maintenance. No validated human dose exists, which is why the card labels every figure as the vendor description.
The human half-life is not established, and the source file notes the vendor says so explicitly; the only detection work found was veterinary, measuring the N-acetylated metabolite LKKTETQ in horses. On the anti-doping side there is no ambiguity: thymosin beta-4 and its derivatives including TB-500 are named in WADA class S2, so the peptide is prohibited and a tested athlete should not touch it.
The 5 mg vial is listed on this page as research material, with international shipping with a 4 to 10 day transit window options in the selector above. Price and stock appear against the option you choose. International shipping is listed at 45.00 USD with a transit window of four to ten days and orders are handled within one to two business days; at the last check every option on this page was out of stock.
Be the first to share your experience with Zyvex Pharmaceuticals TB-500 5 mg Thymosin Peptide Vial
Log in to write a reviewComplete the cycle
Out of stock
Out of stock
Out of stock